封面
市场调查报告书
商品编码
1571814

医用级超高分子量聚乙烯单体市场规模、份额和趋势分析报告:按应用、按地区和细分市场预测,2024-2030年

Medical Grade Ultra High Molecular Weight Polyethylene Monomer Market Size, Share & Trends Analysis Report By Application (Knee Replacement, Hip Replacement), By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

医用级超高分子量聚乙烯单体市场成长与趋势:

根据Grand View Research, Inc.最新报告显示,到2030年,全球医用级超高分子量聚乙烯单体市场规模将达到41.6亿美元,2024年至2030年复合年增长率为9.5%。

由于其优异的性能,如高衝击强度、低反应性和良好的柔韧性,这种材料在医疗植入中的有效性预计将在预测期内推动其需求。

UHMWPE 是一种长链材料,可实现有效的负载转移,使其适合植入应用。这种材料非常柔韧并且具有很高的衝击强度。它也比金属轻。由于所有这些特性,近年来医疗应用中对 UHMWPE 的需求有所增加,预计这一趋势在预测期内将持续下去。

超高分子量聚乙烯因其有效性和多功能性而被用于关节重建手术。世界各地对关节重建手术的需求正在迅速增加。老年人口的增加、生活方式的改变以及身体素质的缺乏是造成这一趋势的因素。预计这一趋势将对未来八年的整体需求产生积极影响。

主要行业参与者正在寻求开发具有更长寿命、更高舒适度和更强机械性能的创新植入产品。该市场的特点是少数公司占据了压倒性的收益占有率。公司正在努力扩大产品系列和生产能力,以满足不断增长的需求。

医疗级超高分子量聚乙烯单体市场报告要点

  • 由于骨关节炎和其他关节相关疾病的盛行率不断增加,到2023年,全膝关节关节重建手术将占40.9%的压倒性份额。
  • 由于骨关节炎和类风湿性关节炎盛行率不断上升,预计全髋置换术在预测期内将以最快的复合年增长率增长。
  • 亚太地区医用级超高分子量聚乙烯单体市场2023年市场占有率为40.5%。
  • 北美医用级超高分子量聚乙烯单体市场2023年市场占有率为26.0%。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章医用级超高分子量聚乙烯 (UHMWPE) 单体市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 医用级超高分子量聚乙烯 (UHMWPE) 单体市场分析工具
    • 波特的分析
    • PESTEL分析

第四章医用级超高分子量聚乙烯(UHMWPE)单体市场:应用估算与趋势分析

  • 细分仪表板
  • 医用级超高分子量聚乙烯 (UHMWPE) 单体市场:应用变化分析,百万美元,数量:千吨,2023 年和 2030 年
  • 全髋置换术
  • 膝关节关节重建
  • 肩关节关节重建
  • 脚踝置换术
  • 小关节

第五章医用级超高分子量聚乙烯(UHMWPE)单体市场:区域估计与趋势分析

  • 2023 年和 2030 年医用级超高分子量聚乙烯 (UHMWPE) 单体按地区市场占有率,百万美元,数量:千吨
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 印尼
    • 越南
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争状况

  • 最新趋势与影响分析:主要市场参与企业
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Celanese Corporation
    • DSM Biomedical
    • Honeywell International Inc.
    • Mitsui Chemicals, Inc.
    • TEIJIN LIMITED
    • LyondellBasell Industries Holdings BV
    • Orthoplastics Ltd.
    • Tianyi Biomedical Technology Co., Ltd.
    • Quadrant Engineering Plastic Products(Mitsubishi Chemical Advanced Materials)
    • Asahi Kasei Corporation
简介目录
Product Code: GVR-1-68038-272-3

Medical Grade Ultra High Molecular Weight Polyethylene Monomer Market Growth & Trends:

The global medical grade ultra high molecular weight polyethylene monomer market size is expected to reach USD 4.16 billion by 2030, registering a CAGR of 9.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. The effectiveness of the material in medical implants due to its superior properties such as high impact strength, low reactivity, and good flexibility is expected to drive the demand over the forecast period.

UHMWPE is a material having long chains which enable it to efficiently transfer load, thus making it suitable for implantation applications. The material is extremely pliable and has good impact strength. The material has less weight as compared to metals. All these properties have increased the demand for UHMWPE for medical applications in the recent past, and this trend is expected to continue over the forecast period.

Joint replacement surgeries use ultra high molecular weight polyethylene due to its effectiveness and versatility options. There has been a surge in demand for joint replacement surgeries across the globe. Rising geriatric population, changing lifestyle and lack of fitness are the contributing factors for this trend. This trend is expected to benefit the overall demand over next eight years.

Major industry participants are trying to develop innovative implantable products which have a longer life, are more comfortable, and give a strong mechanical performance. The market is characterized by few companies occupying a dominant revenue share. Companies are taking steps to increase the product portfolio and production capacity to meet the rising demand.

Medical Grade Ultra High Molecular Weight Polyethylene Monomer Market Report Highlights:

  • Knee replacements have accounted for the dominant share of 40.9% in 2023 owing to the increasing prevalence of osteoarthritis and other joint-related conditions.
  • Total hip replacement surgeries are expected to emerge at the fastest-growing CAGR during the forecast period owing to the escalating prevalence of osteoarthritis and rheumatoid arthritis.
  • The medical grade ultra high molecular weight polyethylene monomers market in Asia Pacific registered 40.5% as the dominant market share in 2023.
  • The North America medical grade ultra high molecular weight polyethylene monomers market secured 26.0% of the market share in 2023 owing to the region's growing investment in the healthcare infrastructure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million) (Volume in Kilotons)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market: Application Movement Analysis, USD Million, Volume in Kilotons, 2023 & 2030
  • 4.3. Total Hip Replacement
    • 4.3.1. Total Hip Replacement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 4.4. Knee Replacement
    • 4.4.1. Knee Replacement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 4.5. Shoulder Replacement
    • 4.5.1. Shoulder Replacement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 4.6. Ankle Replacement
    • 4.6.1. Ankle Replacement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 4.7. Small Joints
    • 4.7.1. Small Joints Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)

Chapter 5. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market: Regional Estimates & Trend Analysis

  • 5.1. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer tMarket Share, By Region, 2023 & 2030, USD Million, Volume in Kilotons
  • 5.2. North America
    • 5.2.1. North America Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.2.2. U.S.
      • 5.2.2.1. U.S. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.2.3. Canada
      • 5.2.3.1. Canada Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.2.4. Mexico
      • 5.2.4.1. Mexico Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.3. Europe
    • 5.3.1. Europe Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.2. U.K.
      • 5.3.2.1. U.K. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.3. Germany
      • 5.3.3.1. Germany Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.4. France
      • 5.3.4.1. France Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.5. Italy
      • 5.3.5.1. Italy Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.6. Spain
      • 5.3.6.1. Spain Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.7. Russia
      • 5.3.7.1. Russia Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.8. Demark
      • 5.3.8.1. Denmark Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.9. Sweden
      • 5.3.9.1. Sweden Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.10. Norway
      • 5.3.10.1. Norway Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.2. China
      • 5.4.2.1. China Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.3. Japan
      • 5.4.3.1. Japan Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.4. India
      • 5.4.4.1. India Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.5. Australia
      • 5.4.5.1. Australia Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.6. South Korea
      • 5.4.6.1. South Korea Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.7. Indonesia
      • 5.4.7.1. Indonesia Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.8. Vietnam
      • 5.4.8.1. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.5. Latin America
    • 5.5.1. Latin America Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.5.2. Brazil
      • 5.5.2.1. Brazil Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.5.3. Argentina
      • 5.5.3.1. Argentina Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.6. Middle East and Africa
    • 5.6.1. Middle East and Africa Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. Saudi Arabia
      • 5.6.2.1. Saudi Arabia Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.6.3. South Africa
      • 5.6.3.1. South Africa Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.6.4. UAE
      • 5.6.4.1. UAE Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.6.5. Kuwait
      • 5.6.5.1. Kuwait Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis by Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Heat Map Analysis
  • 6.4. Company Profiles
    • 6.4.1. Celanese Corporation
      • 6.4.1.1. Participant's Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Recent Developments/ Strategic Initiatives
    • 6.4.2. DSM Biomedical
      • 6.4.2.1. Participant's Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Recent Developments/ Strategic Initiatives
    • 6.4.3. Honeywell International Inc.
      • 6.4.3.1. Participant's Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Recent Developments/ Strategic Initiatives
    • 6.4.4. Mitsui Chemicals, Inc.
      • 6.4.4.1. Participant's Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Recent Developments/ Strategic Initiatives
    • 6.4.5. TEIJIN LIMITED
      • 6.4.5.1. Participant's Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Recent Developments/ Strategic Initiatives
    • 6.4.6. LyondellBasell Industries Holdings B.V.
      • 6.4.6.1. Participant's Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Recent Developments/ Strategic Initiatives
    • 6.4.7. Orthoplastics Ltd.
      • 6.4.7.1. Participant's Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Recent Developments/ Strategic Initiatives
    • 6.4.8. Tianyi Biomedical Technology Co., Ltd.
      • 6.4.8.1. Participant's Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Recent Developments/ Strategic Initiatives
    • 6.4.9. Quadrant Engineering Plastic Products (Mitsubishi Chemical Advanced Materials)
      • 6.4.9.1. Participant's Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Recent Developments/ Strategic Initiatives
    • 6.4.10. Asahi Kasei Corporation
      • 6.4.10.1. Participant's Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Recent Developments/ Strategic Initiatives